Literature DB >> 11716095

Relationship between Trypanosoma cruzi and human chagasic megaesophagus: blood and tissue parasitism.

E Lages-Silva1, E Crema, L E Ramirez, A M Macedo, S D Pena, E Chiari.   

Abstract

The persistence of Trypanosoma cruzi in tissue and blood of 52 patients in the digestive form of chronic Chagas disease was studied. These patients had chagasic megaesophagus and underwent corrective surgery. Parasitologic (xenodiagnosis, hemoculture, or both), histopathologic (hematoxylin and eosin, and peroxidase-anti-peroxidase staining), and molecular (polymerase chain reaction [PCR] followed by slot-blot hybridization) tests were used in the analysis. The presence of T. cruzi, its genomic fragments, or its antigens could be detected in 98% (51 of 52) of the patients. The parasite was randomly identified in 76.9% of esophageal tissues and in 90.4% by PCR and in 73.1% by parasitologic methods from the blood. Fifty percent (26 of 52) of tissue samples had inflammation, 80.8% of which was associated with the parasite. Trypanosoma cruzi was also identified unassociated with inflammatory alterations. Higher tissue parasitism and intense inflammatory processes were observed in esophageal tissue from patients with Grade IV megaesophagus. These data demonstrate that in the digestive form of Chagas' disease, particularly in cases of megaesophagus, T. cruzi is frequently found, both in blood and tissues and may contribute to the pathogenic mechanisms involved.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11716095     DOI: 10.4269/ajtmh.2001.65.435

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  19 in total

1.  Use of the Trypanosoma cruzi recombinant complement regulatory protein to evaluate therapeutic efficacy following treatment of chronic chagasic patients.

Authors:  Wendell S F Meira; Lúcia M C Galvão; Eliane D Gontijo; George L L Machado-Coelho; Karen A Norris; Egler Chiari
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

2.  Variability of kinetoplast DNA gene signatures of Trypanosoma cruzi II strains from patients with different clinical forms of Chagas' disease in Brazil.

Authors:  Eliane Lages-Silva; Luis Eduardo Ramírez; André Luiz Pedrosa; Eduardo Crema; Lúcia Maria da Cunha Galvão; Sérgio Danilo Junho Pena; Andrea Mara Macedo; Egler Chiari
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

Review 3.  Pathogenesis of chagas' disease: parasite persistence and autoimmunity.

Authors:  Antonio R L Teixeira; Mariana M Hecht; Maria C Guimaro; Alessandro O Sousa; Nadjar Nitz
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

4.  Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas' disease.

Authors:  Juan C Engel; Kenny K H Ang; Steven Chen; Michelle R Arkin; James H McKerrow; Patricia S Doyle
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

5.  Sequencing and analysis of chromosomal extremities of Trypanosoma rangeli in comparison with Trypanosoma cruzi lineages.

Authors:  Marlene Cabrine-Santos; Luis Eduardo Ramírez; Eliane Lages-Silva; Bruna Ferreira de Souza; André Luiz Pedrosa
Journal:  Parasitol Res       Date:  2010-10-01       Impact factor: 2.289

6.  Functional and histopathological study of the pancreas in hamsters (Mesocricetus auratus) infected and reinfected with Trypanosoma cruzi.

Authors:  Vitorino Modesto dos Santos; Marcus Aurelho de Lima; Marlene Cabrine-Santos; Daniela de Stefani Marquez; Gilberto de Araújo Pereira; Eliane Lages-Silva; Luis Eduardo Ramírez
Journal:  Parasitol Res       Date:  2004-09       Impact factor: 2.289

7.  Tissue-specific oxidative imbalance and mitochondrial dysfunction during Trypanosoma cruzi infection in mice.

Authors:  Jian-Jun Wen; Monisha Dhiman; Elbert B Whorton; Nisha Jain Garg
Journal:  Microbes Infect       Date:  2008-07-16       Impact factor: 2.700

8.  Socio-economic status and lifestyle factors are associated with achalasia risk: A population-based case-control study.

Authors:  Helen G Coleman; Ronan T Gray; Kar W Lau; Conall McCaughey; Peter V Coyle; Liam J Murray; Brian T Johnston
Journal:  World J Gastroenterol       Date:  2016-04-21       Impact factor: 5.742

9.  PCR assay for monitoring Trypanosoma cruzi parasitemia in childhood after specific chemotherapy.

Authors:  Lúcia M C Galvão; Egler Chiari; Andréa M Macedo; Alejandro O Luquetti; Simonne A Silva; Ana Lúcia S S Andrade
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

10.  Analytical Validation of Quantitative Real-Time PCR Methods for Quantification of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease Patients.

Authors:  Juan Carlos Ramírez; Carolina Inés Cura; Otacilio da Cruz Moreira; Eliane Lages-Silva; Natalia Juiz; Elsa Velázquez; Juan David Ramírez; Anahí Alberti; Paula Pavia; María Delmans Flores-Chávez; Arturo Muñoz-Calderón; Deyanira Pérez-Morales; José Santalla; Paulo Marcos da Matta Guedes; Julie Peneau; Paula Marcet; Carlos Padilla; David Cruz-Robles; Edward Valencia; Gladys Elena Crisante; Gonzalo Greif; Inés Zulantay; Jaime Alfredo Costales; Miriam Alvarez-Martínez; Norma Edith Martínez; Rodrigo Villarroel; Sandro Villarroel; Zunilda Sánchez; Margarita Bisio; Rudy Parrado; Lúcia Maria da Cunha Galvão; Antonia Cláudia Jácome da Câmara; Bertha Espinoza; Belkisyole Alarcón de Noya; Concepción Puerta; Adelina Riarte; Patricio Diosque; Sergio Sosa-Estani; Felipe Guhl; Isabela Ribeiro; Christine Aznar; Constança Britto; Zaida Estela Yadón; Alejandro G Schijman
Journal:  J Mol Diagn       Date:  2015-09       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.